CRP and atherosclerosis: During STEMI, proinflammatory substrates released from necrotic myocardial cells cause an inflammatory response both locally and systemically; CRP is a well-known acute phase reactant and is used as a marker for atherosclerosis.[15] Previous studies have shown that CRP localizes in the infarct area, combines with complement factors in this region, and is stored.